DANIEL WEINTRAUB: Open Payments
NPI 1306865779 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$143,625 in 32 payments from 6 companies in 2025. Trend: 2023 $84,315 · 2024 $126,331 · 2025 $143,625
Consulting: $128,732Travel & lodging: $14,034Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 10 | $101,122 |
| Novo Nordisk AS | 6 | $20,493 |
| ABBVIE INC. | 10 | $9,752 |
| Eli Lilly and Company | 4 | $8,412 |
| Boehringer Ingelheim International GmbH | 1 | $2,225 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $1,620 |
Products named: Leqembi.
Industry payments across PA — which companies pay providers there.
